Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 22687516)

1.

Amino acid-derived 1,2-benzisothiazolinone derivatives as novel small-molecule antifungal inhibitors: identification of potential genetic targets.

Alex D, Gay-Andrieu F, May J, Thampi L, Dou D, Mooney A, Groutas W, Calderone R.

Antimicrob Agents Chemother. 2012 Sep;56(9):4630-9. doi: 10.1128/AAC.00477-12. Epub 2012 Jun 11.

2.

Fungicide activity of 5-(4-chlorobenzylidene)-(Z)-2-dimethylamino-1,3-thiazol-4-one against Cryptococcus neoformans.

Insuasty B, Gutiérrez A, Quiroga J, Abonia R, Nogueras M, Cobo J, Svetaz L, Raimondi M, Zacchino S.

Arch Pharm (Weinheim). 2010 Jan;343(1):48-53. doi: 10.1002/ardp.200900187.

PMID:
19927310
3.

Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance.

Monk BC, Niimi K, Lin S, Knight A, Kardos TB, Cannon RD, Parshot R, King A, Lun D, Harding DR.

Antimicrob Agents Chemother. 2005 Jan;49(1):57-70.

4.

Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.

Coste AT, Ramsdale M, Ischer F, Sanglard D.

Microbiology. 2008 May;154(Pt 5):1491-501. doi: 10.1099/mic.0.2007/016063-0.

5.

The novel equisetin-like compound, TA-289, causes aberrant mitochondrial morphology which is independent of the production of reactive oxygen species in Saccharomyces cerevisiae.

Quek NC, Matthews JH, Bloor SJ, Jones DA, Bircham PW, Heathcott RW, Atkinson PH.

Mol Biosyst. 2013 Aug;9(8):2125-33. doi: 10.1039/c3mb70056a. Epub 2013 May 28.

PMID:
23715404
6.

T-2307 causes collapse of mitochondrial membrane potential in yeast.

Shibata T, Takahashi T, Yamada E, Kimura A, Nishikawa H, Hayakawa H, Nomura N, Mitsuyama J.

Antimicrob Agents Chemother. 2012 Nov;56(11):5892-7. doi: 10.1128/AAC.05954-11. Epub 2012 Sep 4.

7.

Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence.

Qu Y, Jelicic B, Pettolino F, Perry A, Lo TL, Hewitt VL, Bantun F, Beilharz TH, Peleg AY, Lithgow T, Djordjevic JT, Traven A.

Eukaryot Cell. 2012 Apr;11(4):532-44. doi: 10.1128/EC.05292-11. Epub 2012 Jan 27.

8.

Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.

Billack B, Santoro M, Lau-Cam C.

Microb Drug Resist. 2009 Jun;15(2):77-83. doi: 10.1089/mdr.2009.0872.

PMID:
19432523
9.

Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants.

Sun N, Fonzi W, Chen H, She X, Zhang L, Zhang L, Calderone R.

Antimicrob Agents Chemother. 2013 Jan;57(1):532-42. doi: 10.1128/AAC.01520-12. Epub 2012 Nov 12.

10.

4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I.

Langner CA, Lodge JK, Travis SJ, Caldwell JE, Lu T, Li Q, Bryant ML, Devadas B, Gokel GW, Kobayashi GS, et al.

J Biol Chem. 1992 Aug 25;267(24):17159-69.

12.

Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay.

Tebbets B, Stewart D, Lawry S, Nett J, Nantel A, Andes D, Klein BS.

PLoS One. 2012;7(5):e36021. doi: 10.1371/journal.pone.0036021. Epub 2012 May 4.

13.

Chemical-genetic approaches for exploring the mode of action of natural products.

Lopez A, Parsons AB, Nislow C, Giaever G, Boone C.

Prog Drug Res. 2008;66:237, 239-71. Review.

PMID:
18416308
14.

Synthesis and fungicidal activity of 3,5-dichloropyrazin-2(1H)-one derivatives.

François IE, Cammue BP, Bresseleers S, Fleuren H, Hoornaert G, Mehta VP, Modha SG, Van der Eycken EV, Thevissen K.

Bioorg Med Chem Lett. 2009 Aug 1;19(15):4064-6. doi: 10.1016/j.bmcl.2009.06.024. Epub 2009 Jun 13.

PMID:
19556127
15.

Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.

Cruz MC, Goldstein AL, Blankenship J, Del Poeta M, Perfect JR, McCusker JH, Bennani YL, Cardenas ME, Heitman J.

Antimicrob Agents Chemother. 2001 Nov;45(11):3162-70.

16.

Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.

Shingu-Vazquez M, Traven A.

Eukaryot Cell. 2011 Nov;10(11):1376-83. doi: 10.1128/EC.05184-11. Epub 2011 Sep 16. Review.

17.

Pleofungins, novel inositol phosphorylceramide synthase inhibitors, from Phoma sp. SANK 13899. I. Taxonomy, fermentation, isolation, and biological activities.

Yano T, Aoyagi A, Kozuma S, Kawamura Y, Tanaka I, Suzuki Y, Takamatsu Y, Takatsu T, Inukai M.

J Antibiot (Tokyo). 2007 Feb;60(2):136-42.

PMID:
17420564
18.

Chemical composition and antifungal activity of the essential oils of Lavandula viridis L'Her.

Zuzarte M, Gonçalves MJ, Cavaleiro C, Canhoto J, Vale-Silva L, Silva MJ, Pinto E, Salgueiro L.

J Med Microbiol. 2011 May;60(Pt 5):612-8. doi: 10.1099/jmm.0.027748-0. Epub 2011 Feb 14.

PMID:
21321363
19.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.

Mitsuyama J, Nomura N, Hashimoto K, Yamada E, Nishikawa H, Kaeriyama M, Kimura A, Todo Y, Narita H.

Antimicrob Agents Chemother. 2008 Apr;52(4):1318-24. doi: 10.1128/AAC.01159-07. Epub 2008 Jan 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk